These insights collectively highlight the importance of early intervention strategies that target ICAM1 and its downstream NF‐κB signaling to alleviate local inflammation, protect BBB function, and promote brain tissue recovery following ICAS. Here, NFKB1 is linked to familial isolated congenital asplenia.